Correlation of von Willebrand factor and platelets with acute ischemic stroke etiology and revascularization outcome: an immunohistochemical study
Oana Madalina Mereuta,Mehdi Abbasi,Jorge L Arturo Larco,Daying Dai,Yang Liu,Santhosh Arul,Ramanathan Kadirvel,Ricardo A Hanel,Albert J Yoo,Mohammed A Almekhlafi,Kennith F Layton,Josser E Delgado Almandoz,Peter Kvamme,Vitor Mendes Pereira,Babak S Jahromi,Raul G Nogueira,Matthew J Gounis,Biraj Patel,Amin Aghaebrahim,Eric Sauvageau,Parita Bhuva,Jazba Soomro,Andrew M Demchuk,Ike C Thacker,Yasha Kayan,Alexander Copelan,Pouya Nazari,Donald Robert Cantrell,Diogo C Haussen,Alhamza R Al-Bayati,Mahmoud Mohammaden,Leonardo Pisani,Gabriel Martins Rodrigues,Ajit S Puri,John Entwistle,Alexander Meves,Luis Savastano,Harry J Cloft,Shahid M Nimjee,Robert D McBane 2nd,David F Kallmes,Waleed Brinjikji
DOI: https://doi.org/10.1136/neurintsurg-2022-018645
Abstract:Background: Platelets and von Willebrand factor (vWF) are key components of acute ischemic stroke (AIS) emboli. We aimed to investigate the CD42b (platelets)/vWF expression, its association with stroke etiology and the impact these components may have on the clinical/procedural parameters. Methods: CD42b/vWF immunostaining was performed on 288 emboli collected as part of the multicenter STRIP Registry. CD42b/VWF expression and distribution were evaluated. Student's t-test and χ2 test were performed as appropriate. Results: The mean CD42b and VWF content in clots was 44.3% and 21.9%, respectively. There was a positive correlation between platelets and vWF (r=0.64, p<0.001**). We found a significantly higher vWF level in the other determined etiology (p=0.016*) and cryptogenic (p=0.049*) groups compared with cardioembolic etiology. No significant difference in CD42b content was found across the etiology subtypes. CD42b/vWF patterns were significantly associated with stroke etiology (p=0.006*). The peripheral pattern was predominant in atherosclerotic clots (36.4%) while the clustering (patchy) pattern was significantly associated with cardioembolic and cryptogenic origin (66.7% and 49.8%, respectively). The clots corresponding to other determined etiology showed mainly a diffuse pattern (28.1%). Two types of platelets were distinguished within the CD42b-positive clusters in all emboli: vWF-positive platelets were observed at the center, surrounded by vWF-negative platelets. Thrombolysis correlated with a high platelet content (p=0.03*). vWF-poor and peripheral CD42b/vWF pattern correlated with first pass effect (p=0.03* and p=0.04*, respectively). Conclusions: The vWF level and CD42b/vWF distribution pattern in emboli were correlated with AIS etiology and revascularization outcome. Platelet content was associated with response to thrombolysis.